Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
A Maternal Device to Reduce the Risk of Stillbirth and Low Birth-Weight
Sponsor: Allan Kember
Listed as NCT02379728, this NA trial focuses on Fetal Growth Retardation and Fetal Hypoxia and remains completed. Sponsored by Allan Kember, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
May 2020 — Sep 2020 [monthly]
Completed NA
-
Jun 2018 — May 2020 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allan Kember
- Global Innovations for Reproductive Health and Life
- Grand Challenges Canada
- Innovative Canadians for Change
- Kaishin Chu Design
- Korle-Bu Teaching Hospital, Accra, Ghana
For direct contact, visit the study record on ClinicalTrials.gov .